# K133264: Nmi Picc Iii

- Pathway: 510(k) (Special)
- Applicant: Navilyst Medical, Inc.
- Decided: Nov 20, 2013 after 28 days
- Product code: LJS (Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days)
- Device class: 2
- Regulation: 21 CFR 880.5970
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 12 generations back to K001901 (2000). 45 ancestors in all.
6 later devices descend from it; 2 cite it directly.
2 of 52 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K131942: Nmi Picc Iii Catheter, Nmi Hpicc Iii Catheter, Navilyst Medical, Inc. (2013) Summary page 1.

## Most influential descendants
- K140266: Nmi Picc IV (2014), 3 descendants of its own
- K150527: Xcela Power Injectable PICC (2015), 1 descendant of its own
- K153469: Cathtong I PICC Catheter (2016), 0 descendants of its own
- K152409: Xcela PICC with PASV, Xcela Hybrid PICC with PASV, Xcela Power Injectable PICC (2015), 0 descendants of its own
- K150109: Arrow Pressure Injectable Jugular Axillo-subclavian Central Catheter (JACC) with Sustain Technology (2015), 0 descendants of its own

## Indications for use
The NMI P1CC III is indicated for short- or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients, the sampling of blood, for central venous pressure monitoring and for power injection of contrast media.

Source page: https://510kreport.com/device/K133264
Methodology: https://510kreport.com/methodology